.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Cipla
Accenture
Fish and Richardson
Cerilliant
Covington
Queensland Health
Deloitte
Express Scripts

Generated: June 24, 2017

DrugPatentWatch Database Preview

BUPHENYL Drug Profile

« Back to Dashboard

What is the patent landscape for Buphenyl, and what generic Buphenyl alternatives are available?

Buphenyl is a drug marketed by Horizon Pharma Inc and is included in two NDAs.

The generic ingredient in BUPHENYL is sodium phenylbutyrate. There are one thousand three hundred and seventy-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sodium phenylbutyrate profile page.

Summary for Tradename: BUPHENYL

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list47
Clinical Trials: see list8
Patent Applications: see list634
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUPHENYL at DailyMed

Pharmacology for Tradename: BUPHENYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
TABLET;ORAL020572-001May 13, 1996ABRXYesYes► Subscribe► Subscribe
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
POWDER;ORAL020573-001Apr 30, 1996ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BUPHENYL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
TABLET;ORAL020572-001May 13, 19964,457,942► Subscribe
Horizon Pharma Inc
BUPHENYL
sodium phenylbutyrate
POWDER;ORAL020573-001Apr 30, 19964,457,942► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
US Army
Deloitte
Moodys
Fish and Richardson
Medtronic
Accenture
Julphar
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot